Medical Oncology

Doç. Dr. Erkan Kayıkçıoğlu

Doctor and researcher Liv Hospital Bahçeşehir İstanbul
Breast Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: livhospital.com.

  • Kişiselleştirilmiş Tıp
  • İmmünoterapi
  • Meme kanseri
  • Akciğer Kanseri
  • Kolon Kanseri
  • Prostat Kanseri
  • Mide Kanseri
  • Karaciğer (HCC) Kanseri
  • Serviks Kanseri
  • Endometrium Kanseri
  • Over Kanseri
  • Mesane Kanseri
  • Böbrek Kanseri
  • Malign Melanom
  • Pankreas Kanseri
  • Testis Kanseri
  • Larinks Kanseri
  • Nöroendokrin Tümör
  • Ösefagus Kanseri
  • Klinik Çalışmalar
  • Kanser Genetiği

CV

Education and experience

From source

Experience

  • 2010-2013Seydişehir Devlet Hastanesi İç Hastalıkları Uzmanılivhospital.com
  • 2013-2015Antalya Özel Yaşam Hastanesi İç Hastalıkları Uzmanılivhospital.com
  • 2015-2018Sağlık Bilimleri Üniversitesi Antalya Eğitim Araştırma Hastanesi Tıbbı Onkoloji Fellowlivhospital.com
  • 2018-2020Recep Tayyip Erdoğan Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji uzmanılivhospital.com
  • 2020-2021Sağlık Bilimleri Üniversitesi Antalya Eğitim Araştırma Hastanesi Tıbbı Onkoloji uzmanılivhospital.com
  • 2021-2023Süleyman Demirel Üniversitesi, Tıp Fakültesi Doktor Öğretim Üyesilivhospital.com
  • 2023Beylikdüzü Kolan Hastanesilivhospital.com

Education

  • EducationHacettepe Üniversitesi Tıp Fakültesi (İngilizce)livhospital.com

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologylivhospital.comFrom source
  • InstitutionLiv Hospital Bahçeşehirlivhospital.comFrom source
  • Area of workBreast NeoplasmsExtracted from 4 publications · Model version —From source
  • Publications54 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 20:56https://www.livhospital.com/doc-dr-erkan-kayikcioglulivhospital.com

Scientific work

Publications on Breast Neoplasms

54 publications

  1. In Regard to Peltenburg et al

    Practical Radiation Oncology, 2026

    DOI 10.1016/j.prro.2026.01.020 PMID 42971673 Source: OpenAlex

  2. HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy

    Turkish Journal of Clinics and Laboratory, 2025

    DOI 10.18663/tjcl.1639022 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  3. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Clinical Breast Cancer, 2025

    DOI 10.1016/j.clbc.2025.03.003 PMID 40190010 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. The Gustave Roussy immune score as a novel biomarker for predicting survival in patients with isocitrate dehydrogenase wild-type glioblastoma treated with the Stupp protocol

    Expert Review of Anticancer Therapy, 2025

    DOI 10.1080/14737140.2025.2555467 PMID 40883857 1 citation (Europe PMC) Source: OpenAlex

  5. Refining risk stratification in PSMA-PET guided salvage radiotherapy: methodological and translational considerations

    Radiotherapy and Oncology, 2025

    DOI 10.1016/j.radonc.2025.111234 PMID 41171646 Source: OpenAlex

  6. Minimally Invasive Surgery Versus SABR in Stage IA NSCLC: Interpreting Real-World Evidence with Caution

    Clinical Lung Cancer, 2025

    DOI 10.1016/j.cllc.2025.11.002 PMID 41314019 Source: OpenAlex

  7. Beyond BMI: Metabolic and Inflammatory Determinants of Recurrence After Neoadjuvant Therapy in Breast Cancer

    Clinical Breast Cancer, 2025

    DOI 10.1016/j.clbc.2025.11.004 PMID 41319354 Source: OpenAlex

  8. Subcutaneous pertuzumab–trastuzumab: Efficiency, safety, and the biosimilar horizon

    The Breast, 2025

    DOI 10.1016/j.breast.2025.104651 PMID 41274854 Open-access full textSource: OpenAlex

  9. Machine learning for predicting colon cancer recurrence

    Surgical Oncology, 2024

    DOI 10.1016/j.suronc.2024.102079 PMID 38688191 9 citations (Europe PMC) Source: OpenAlex

  10. Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer

    Cureus, 2024

    DOI 10.7759/cureus.71251 PMID 39525139 9 citations (Europe PMC) Open-access full textSource: OpenAlex

View all 54 publications